Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older of any gender
- People who are showing signs of an acute stroke or a brief stroke-like episode (sometimes called a "mini-stroke"), and who are able to take a combination of two blood-thinning medications at the time of screening
- People who arrive within 24 hours of their symptoms starting, or between 24 and 96 hours after symptoms started if they are already taking or are planned to take a combination of two blood-thinning medications
Who may not be able to join:
- People who are already taking strong blood-thinning medication (anticoagulants), or who clearly need to start taking them after their stroke event — for example, people who have a heart rhythm condition called atrial fibrillation
- People who have previously had a bone marrow transplant using donor cells from another person
- People who have previously had a liver transplant
- People who are unable to give their own consent and do not have someone available (such as a family member or legal representative) who can give consent on their behalf
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rachael M Stone, PharmD, University of Virginia
Phone: 434-297-6777
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of patients discharged from University of Virginia (UVA) Health on dual antiplatelet therapy with a diagnosis of AIS/TIA meeting eligibility criteria upon presentation that are successfully genotyped; Average turnaround time of genotype result from time of collection of blood sample to time result is entered into the electronic health record
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.